Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
American Journal of Hematology|May 20, 1999
Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995R A Mesa, M N Silverstein, S J Jacobsen, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indicationsA Tefferi, M N Silverstein, R M Petitt, et al.Leukemia|May 17, 2003
In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasiaR A Mesa, A Tefferi, L A Gray, et al.British Journal of Haematology|May 31, 2001
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasiaA Tefferi, R A Mesa, G Schroeder, et al.American Journal of Alzheimer'S Disease and Other Dementias|May 13, 2023
Diastolic Blood Pressure and Cognitive Functioning: Differences by Systolic Blood Pressure Among US AdultsA Mathew, R A Mesa, L Nahodyl, et al.Leukemia Research|April 3, 2007
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosisM A Elliott, S Verstovsek, D Dingli, et al.Leukemia|November 6, 2010
A phase-2 trial of low-dose pomalidomide in myelofibrosisK H Begna, R A Mesa, A Pardanani, et al.Ecology and Evolution|June 22, 2013
Effects of clonality on the genetic variability of rare, insular species: the case of Ruta microcarpa from the Canary IslandsM Meloni, A Reid, J Caujapé-Castells, et al.Leukemia|August 2, 2016
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosisS Verstovsek, M Talpaz, E Ritchie, et al.Leukemia|January 25, 2008
Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survivalA Tefferi, T L Lasho, J Huang, et al.Pageof 3